Ischemic Stroke: Challenging Market, Huge Need
Time is critical when a patient suffers from a stroke.
ron cohen
Ampyra Walks Away with FDA Approval
The U.S. Food and Drug Administration (FDA) has approved the first drug designed to improve walking in adults with multiple sclerosis.